Skip to main content
Latent Space

🔬ESMFold2: The Bitter Lesson is Coming for Proteins - Alex Rives, BioHub

70 min episode · 3 min read
·
Alex Rives

Episode

70 min

Read time

3 min

Topics

Startups, Fundraising & VC, Design & UX

AI-Generated Summary

Key Takeaways

  • âś“Metagenomic data eliminates scaling bottleneck: ESM2 showed diminishing returns because it trained only on UniRef sequences. Adding metagenomic data — sequences collected from hydrothermal vents, deep oceans, soil, and gut environments — restored clean scaling laws for ESMC. The lesson: biological diversity of training data matters more than parameter count alone. Researchers building bio-foundation models should prioritize sourcing sequences from extreme and underrepresented ecological niches before scaling compute.
  • âś“Sparse autoencoders reveal emergent biological hierarchy: Training sparse autoencoders across all layers of ESMC's 300M, 600M, and 6B parameter models reveals a feature hierarchy matching decades of experimental biology — from basic biochemical properties up to abstract functional themes — without any prior biological knowledge encoded. Teams doing mechanistic interpretability on biology models should apply SAEs layer-by-layer to surface latent biological variables the model uses for sequence prediction.
  • âś“Antibody design without MSAs reaches therapeutic affinity: ESMC designs single-chain antibodies (SCFVs) that reach binding affinity levels required for therapeutic function, without using multiple sequence alignments. Antibodies evolve toward diversity rather than conservation, making MSA-based approaches structurally disadvantaged. Protein engineers targeting therapeutic modalities — which represent roughly 25% of new drugs — should evaluate world-model search approaches over MSA-dependent pipelines for antibody CDR design.
  • âś“World-model search replaces explicit programming for protein design: Rather than encoding biological rules or structural priors, ESMC treats protein design as a search problem over a predictive world model. Mini-protein binders and SCFVs emerge from searching the model's learned representation space against design criteria. Computational biology teams can operationalize this by using ESMC's MIT-licensed weights to run generative searches rather than building task-specific supervised models for each design objective.
  • âś“Atlas of 1.1 billion predicted structures enables cross-evolution linkage: Biohub clustered 6.8 billion sequences at 70% sequence identity, producing ~1.2 billion clusters with predicted structures. Computing features across all clusters surfaces connections between distantly related proteins — such as gene editing systems with no sequence similarity but shared structural motifs. Researchers mining for novel enzymes or gene editors should query this atlas using feature-space proximity rather than sequence-based BLAST searches.

What It Covers

Alex Rives, Head of Science at Biohub, presents ESM Cambrian (ESMC), a 6-billion parameter protein language model trained on 6.8 billion non-redundant protein sequences. The model predicts protein structure, enables antibody design, and uses sparse autoencoders to reveal emergent biological features — all without multiple sequence alignments or hand-engineered priors.

Key Questions Answered

  • •Metagenomic data eliminates scaling bottleneck: ESM2 showed diminishing returns because it trained only on UniRef sequences. Adding metagenomic data — sequences collected from hydrothermal vents, deep oceans, soil, and gut environments — restored clean scaling laws for ESMC. The lesson: biological diversity of training data matters more than parameter count alone. Researchers building bio-foundation models should prioritize sourcing sequences from extreme and underrepresented ecological niches before scaling compute.
  • •Sparse autoencoders reveal emergent biological hierarchy: Training sparse autoencoders across all layers of ESMC's 300M, 600M, and 6B parameter models reveals a feature hierarchy matching decades of experimental biology — from basic biochemical properties up to abstract functional themes — without any prior biological knowledge encoded. Teams doing mechanistic interpretability on biology models should apply SAEs layer-by-layer to surface latent biological variables the model uses for sequence prediction.
  • •Antibody design without MSAs reaches therapeutic affinity: ESMC designs single-chain antibodies (SCFVs) that reach binding affinity levels required for therapeutic function, without using multiple sequence alignments. Antibodies evolve toward diversity rather than conservation, making MSA-based approaches structurally disadvantaged. Protein engineers targeting therapeutic modalities — which represent roughly 25% of new drugs — should evaluate world-model search approaches over MSA-dependent pipelines for antibody CDR design.
  • •World-model search replaces explicit programming for protein design: Rather than encoding biological rules or structural priors, ESMC treats protein design as a search problem over a predictive world model. Mini-protein binders and SCFVs emerge from searching the model's learned representation space against design criteria. Computational biology teams can operationalize this by using ESMC's MIT-licensed weights to run generative searches rather than building task-specific supervised models for each design objective.
  • •Atlas of 1.1 billion predicted structures enables cross-evolution linkage: Biohub clustered 6.8 billion sequences at 70% sequence identity, producing ~1.2 billion clusters with predicted structures. Computing features across all clusters surfaces connections between distantly related proteins — such as gene editing systems with no sequence similarity but shared structural motifs. Researchers mining for novel enzymes or gene editors should query this atlas using feature-space proximity rather than sequence-based BLAST searches.
  • •Virtual Biology Initiative targets cellular-scale data generation: Biohub commits $400M internally and $100M externally to generate cellular biology data at scale, prioritizing perturbation biology, spatial transcriptomics, and multi-modal single-cell measurements. Current cell atlases contain roughly one billion cells; the initiative targets multiple orders of magnitude beyond that. The core design principle mirrors protein modeling: expose the model to interventions across as many cellular contexts as possible to enable generalization to unobserved experiments.

Notable Moment

Rives notes that ESM2 appeared to hit diminishing returns on scaling — which could have ended the research direction entirely. The fix turned out to be data composition, not architecture. Adding metagenomic sequences restored a clean, predictable scaling law, validating the bitter lesson for protein biology years after the initial bet.

Know someone who'd find this useful?

Episode Transcript

So ESMC is all is also approaching programmable biology, but I would say in a very different way. It's approaching it from this kind of world modeling perspective where the idea is basically you have a predictive model and, you know, you're gonna search the world model to find protein molecules that satisfy kind of whatever design criteria that you have. So we've been able to use this to actually now go and design mini protein binders. I think sort of most excitingly, we've been able to use this to actually design antibodies, SCFVs. Hello. Welcome to the Latent Space AI for Science podcast. I'm RJ Haneke, CTO of Mero Omics. Yeah, and, I'm Brandon. Today, it's a pleasure to have Alex Reeves, Head of Science at Biohub. Yeah, would you like to introduce yourself real quick? Yeah, yeah. Thank you for having me here. It's great to be here. I'm Head of Science at Biohub. I'm a computer scientist, and I work on AI for biology, and a lot of my work has been on language models for biology. By the time this podcast is released, you will have put out several new exciting interesting models. Going over them, I couldn't help but have the kind of thought that you might be the most bitter, less until person in protein biology right now. Can you give a little context about what that means for biology and, you know, why you're so committed and excited to this route? Well, I'll take that. I believe in scaling laws. So, you know, I guess I've been working on this for, you know, since, since the summer of twenty eighteen. And so my team, when we were at MediFare, trained, really the first transformer language model for protein biology. And so I guess, you know, I've always thought that there would be kind of emergence of biological information as you train a model to predict the next token, you know, that evolution creates. So our team has really explored that idea over a number of different years, and we've really kind of, I think, seen the scaling curve and really seen as we have have increased models by an order of magnitude kind of in each generation that, you know, there's this emergence of new capabilities. Yeah. So you've been you say emergence of capabilities scaling over generations. You've been working at this, as you said, for, I guess, it would be eight years now or something like that. It didn't always work that way. Right? Like, there was signs that scaling might work. You know, we'll be getting to some new results where it I think, really, you've kind of clearly demonstrated this hypothesis in a way that hasn't happened before. But you seem to have, like, a strong commitment to this in a way that I'm not necessarily sure I would have been so convicted that it would work in the same way. I mean, proteins are not protein language is …

Get the full transcript (12,769 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Latent Space transcripts →

You just read a 3-minute summary of a 67-minute episode.

Get Latent Space summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

Books, tools, and gear mentioned in this episode

SignalCast may earn commission on purchases via these links.

Tools

  • “ESM2 showed diminishing returns because it trained only on UniRef sequences.”
  • by BioHub

    “Alex Rives, Head of Science at Biohub, presents ESM Cambrian (ESMC), a 6-billion parameter protein language model trained on 6.8 billion non-redundant protein sequences.”
  • ESM2By guest

    by BioHub

    “ESM2 showed diminishing returns because it trained only on UniRef sequences. Adding metagenomic data — sequences collected from hydrothermal vents, deep oceans, soil, and gut environments — restored clean scaling laws for ESMC.”
  • “Researchers mining for novel enzymes or gene editors should query this atlas using feature-space proximity rather than sequence-based BLAST searches.”

More from Latent Space

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best AI Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Startups & Product Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Latent Space.

Every Monday, we deliver AI summaries of the latest episodes from Latent Space and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime